Jiang C, et al. - The researchers examined the prevalence of chronic pain (one of the most common long-term effects of cancer treatment, correlated with an impaired quality of life, lower adherence to treatment, and higher health care costs) and high-impact chronic pain (chronic pain with major activity restriction) among cancer survivors in the United States via data taken from the National Health Interview Survey (2016-2017). Growth in the population of cancer survivors in the United States was observed. While the number of survivors was 15.5 million in 2016, expectations that this number would strike 26.1 million by 2040 with the help of aging of the population and advancement in early detection and treatment methods. Further, a lack of information regarding the prevalence of, and risk factors for, the development of chronic pain among cancer survivors was also observed. Therefore, in cancer survivors, a better perception of the epidemiology of pain could help notify future health care educational priorities and policies.